<SEC-DOCUMENT>0001493152-24-040294.txt : 20241007
<SEC-HEADER>0001493152-24-040294.hdr.sgml : 20241007
<ACCEPTANCE-DATETIME>20241007163016
ACCESSION NUMBER:		0001493152-24-040294
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241007
DATE AS OF CHANGE:		20241007

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SOLENO THERAPEUTICS INC
		CENTRAL INDEX KEY:			0001484565
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				770523891
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36593
		FILM NUMBER:		241358178

	BUSINESS ADDRESS:	
		STREET 1:		100 MARINE PARKWAY, SUITE 400
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065
		BUSINESS PHONE:		650-213-8444

	MAIL ADDRESS:	
		STREET 1:		100 MARINE PARKWAY, SUITE 400
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Capnia, Inc.
		DATE OF NAME CHANGE:	20100219

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Abingworth Bioventures VII LP
		CENTRAL INDEX KEY:			0001688313
		ORGANIZATION NAME:           	
		IRS NUMBER:				931331173
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144

	BUSINESS ADDRESS:	
		STREET 1:		PRINCES HOUSE
		STREET 2:		38 JERMYN STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 6DN
		BUSINESS PHONE:		44 207 534 1500

	MAIL ADDRESS:	
		STREET 1:		PRINCES HOUSE
		STREET 2:		38 JERMYN STREET
		CITY:			LONDON
		STATE:			X0
		ZIP:			SW1Y 6DN
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Abingworth Bioventures VII LP -->
          <cik>0001688313</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001484565</issuerCik>
      <issuerName>Soleno Therapeutics, Inc.</issuerName>
      <secFileNumber>001-36593</secFileNumber>
      <issuerAddress>
        <com:street1>203 Redwood Shores Parkway, Suite 500</com:street1>
        <com:city>Redwood City</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94065</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>650-213-8444</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Abingworth Bioventures VII LP</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Rule 144 Affiliate</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>BTIG, LLC</name>
        <address>
          <com:street1>350 Bush Street, 9th Floor</com:street1>
          <com:city>San Francisco,</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>2522751</noOfUnitsSold>
      <aggregateMarketValue>125204132.00</aggregateMarketValue>
      <noOfUnitsOutstanding>38871594</noOfUnitsOutstanding>
      <approxSaleDate>10/07/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>10/12/2023</acquiredDate>
      <natureOfAcquisitionTransaction>Acquired in multiple transactions directly from the issuer and upon the exercise of warrants</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>2522751</amountOfSecuritiesAcquired>
      <paymentDate>10/12/2023</paymentDate>
      <natureOfPayment>Cash consideration upon purchase or net exercise</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>10/07/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>09/06/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ John Heard</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
